Grown Rogue International (GRUS.F) 주식 개요크래프트 대마초 회사인 그로운 로그 인터내셔널은 프리미엄 꽃과 꽃에서 추출한 제품에 주력하고 있습니다. 자세히 보기GRUS.F 펀더멘털 분석스노우플레이크 점수가치 평가3/6미래 성장0/6과거 실적0/6재무 건전성5/6배당0/6강점공정 가치 추정치보다 낮은 54.2% 에서 거래위험 분석지난 5년간 매년 수익이 17% 감소했습니다.의미 있는 시가총액이 없습니다($98M)모든 위험 점검 보기GRUS.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.3957.6% 저평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-11m102m2016201920222025202620282031Revenue US$102.4mEarnings US$15.1mAdvancedSet Fair ValueView all narrativesGrown Rogue International Inc. 경쟁사Cumberland PharmaceuticalsSymbol: NasdaqGS:CPIXMarket cap: US$88.0mJushi HoldingsSymbol: OTCPK:JUSH.FMarket cap: US$89.9mbioteSymbol: NasdaqGM:BTMDMarket cap: US$70.8mStablecoin DevelopmentSymbol: NYSEAM:SDEVMarket cap: US$70.2m가격 이력 및 성과Grown Rogue International 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가CA$0.3952주 최고가CA$0.5252주 최저가CA$0.27베타-1.121개월 변동1.63%3개월 변동3.46%1년 변동3.55%3년 변동186.07%5년 변동166.34%IPO 이후 변동451.71%최근 뉴스 및 업데이트공시 • May 14Grown Rogue International Inc. Revises Revenue Guidance for the Year 2026Grown Rogue International Inc. revised revenue guidance for the year 2026. For the year, the company expected revenue guidance to a range of $34 million to $37 million (up from $32 million to $35 million).공시 • Apr 27Grown Rogue International Inc. to Report Q1, 2026 Results on May 12, 2026Grown Rogue International Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 12, 2026공시 • Apr 09Grown Rogue International Inc. Provides Earnings Guidance for 2026 and 2027Grown Rogue International Inc. provided earnings guidance for 2026 and 2027. For 2026, the company expects revenue of $32- $35 million. For 2027, the company expects revenue of $50 - $58 million.공시 • Apr 01Grown Rogue International Inc. to Report Fiscal Year 2025 Final Results on Apr 07, 2026Grown Rogue International Inc. announced that they will report fiscal year 2025 final results on Apr 07, 2026공시 • Mar 31Grown Rogue International Inc. announced delayed annual 10-K filingOn 03/30/2026, Grown Rogue International Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Feb 18Grown Rogue International Inc. to Report Q4, 2025 Results on Mar 31, 2026Grown Rogue International Inc. announced that they will report Q4, 2025 results After-Market on Mar 31, 2026더 많은 업데이트 보기Recent updates공시 • May 14Grown Rogue International Inc. Revises Revenue Guidance for the Year 2026Grown Rogue International Inc. revised revenue guidance for the year 2026. For the year, the company expected revenue guidance to a range of $34 million to $37 million (up from $32 million to $35 million).공시 • Apr 27Grown Rogue International Inc. to Report Q1, 2026 Results on May 12, 2026Grown Rogue International Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 12, 2026공시 • Apr 09Grown Rogue International Inc. Provides Earnings Guidance for 2026 and 2027Grown Rogue International Inc. provided earnings guidance for 2026 and 2027. For 2026, the company expects revenue of $32- $35 million. For 2027, the company expects revenue of $50 - $58 million.공시 • Apr 01Grown Rogue International Inc. to Report Fiscal Year 2025 Final Results on Apr 07, 2026Grown Rogue International Inc. announced that they will report fiscal year 2025 final results on Apr 07, 2026공시 • Mar 31Grown Rogue International Inc. announced delayed annual 10-K filingOn 03/30/2026, Grown Rogue International Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Feb 18Grown Rogue International Inc. to Report Q4, 2025 Results on Mar 31, 2026Grown Rogue International Inc. announced that they will report Q4, 2025 results After-Market on Mar 31, 2026공시 • Oct 21Grown Rogue International Inc. to Report Q3, 2025 Results on Nov 11, 2025Grown Rogue International Inc. announced that they will report Q3, 2025 results After-Market on Nov 11, 2025공시 • Jul 21Grown Rogue International Inc. to Report Q2, 2025 Results on Aug 12, 2025Grown Rogue International Inc. announced that they will report Q2, 2025 results After-Market on Aug 12, 2025공시 • May 02Grown Rogue International Inc., Annual General Meeting, Jul 03, 2025Grown Rogue International Inc., Annual General Meeting, Jul 03, 2025.공시 • Apr 10Grown Rogue International Inc. to Report Q1, 2025 Results on May 13, 2025Grown Rogue International Inc. announced that they will report Q1, 2025 results on May 13, 2025공시 • Feb 03Grown Rogue International Inc. Appoints Josh Rosen as Chief Strategy OfficerGrown Rogue International Inc. announced the hiring of Josh Rosen as the Company's new Chief Strategy Officer. As CSO, Josh will be responsible for leading Grown Rogue's capital allocation, business development and communication strategy, all in support of helping the Company execute on its vision to build a national craft cannabis brand. Prior to joining the Company, Josh has held numerous positions in the cannabis industry including Executive Chairman and CEO of 4Front Ventures and Chief Executive Officer of Vireo Growth Inc. Before joining 4Front in cannabis, Josh worked as a private equity portfolio manager, with the family office of John Sperling, who was a prominent drug reform philanthropist, and before that as an investment research analyst, primarily with Credit Suisse. Josh continues to serve as a Managing Partner of Bengal Capital, a cannabis investment and advisory firm.공시 • Jan 02+ 1 more updateGrown Rogue International Inc. Appoints Andrew Marchington as Chief Financial OfficerGrown Rogue International Inc. appointed Andrew Marchington as the Company's new Chief Financial Officer and Corporate Secretary effective January 1, 2025. Ryan Kee will remain a member of the board of directors supporting the Company with his industry and financial reporting expertise. Andrew Marchington joined the Company as the Senior Vice President, Finance in June 2023. Prior to joining the Company, Andrew served as the Chief Financial Officer of Chalice Brands Ltd. and as Controller of C21 Investments Inc. Andrew is a licensed CPA in Oregon and has served a variety of finance and accounting roles both in and outside of the cannabis industry.공시 • Jun 06Grown Rogue Receives Licensing Approval Approval with the New Jersey Cannabis Regulatory CommissionGrown Rogue International Inc. announced it has received licensing approval with the New Jersey Cannabis Regulatory Commission ("CRC") and closed its first option to acquire 44% of ABCO Garden State, LLC ("ABCO") on May 31, 2024. The transaction details are as follows: Grown Rogue has an option to acquire 70% of ABCO through two options; Option 1 was for 44% and Option 2 is for 26% ABCO has an annual cultivation license with the New Jersey Cannabis Regulatory Commission with local zoning and planning approvals and sufficient power supply Upon receiving licensing approval, the Company purchased Option 1 for USD 1,260,000, which has been paid in cash The Company anticipates exercising Option 2, pending regulatory approval, two years after operations commence. The purchase price for Option 2 is USD 720,000 Grown Rogue has the right to purchase the remaining equity of ABCO at fair market value.공시 • Apr 26Grown Rogue International Inc., Annual General Meeting, Jun 24, 2024Grown Rogue International Inc., Annual General Meeting, Jun 24, 2024.공시 • Mar 03Grown Rogue International Inc. announced delayed 20-F filingOn 03/01/2024, Grown Rogue International Inc. announced that they will be unable to file their next 20-F by the deadline required by the SEC.공시 • Jul 14Grown Rogue International Inc. announced that it has received $5 million in funding from Mindset CapitalOn July 13, 2023, Grown Rogue International Inc. closed the transaction. The transaction was led by retuning investor, Mindset Capital. Additionally, on closing, the company issued to the subscribers under the offering an aggregate of 13,737,500 common share purchase warrants.공시 • Jul 07Grown Rogue International Inc., Annual General Meeting, Oct 24, 2023Grown Rogue International Inc., Annual General Meeting, Oct 24, 2023.공시 • Jul 06Grown Rogue International Inc. announced that it expects to receive $5 million in fundingGrown Rogue International Inc. announced a non-brokered private placement of unsecured convertible debentures with an aggregate principal amount of up to $5,000,000 on July 4, 2023. Each subscriber under the offering shall receive one-half of one common share purchase warrant for each CAD 0.24 ($0.18) of principal amount subscribed. The debentures will mature four years from the closing date, bear interest at a rate equal to 9% per annum, payable in united states currency on the last business day of the month following the end of each calendar quarter and are convertible as set forth below into common shares of the company. The debenture holders will be entitled, at their option, to convert, at any time on or prior to the maturity date, the outstanding Principal Amount and accrued interest into shares at a price per share equal to CAD 0.24 ($0.18). The company may elect to prepay the principal amount together with any interest thereon prior to the maturity date upon providing 30 days’ notice to the debenture holder. Each full Warrant will be exercisable into one share at an exercise price of CAD 0.28 ($0.21) for a period of three years from the closing date and are subject to an acceleration clause that in the event that the shares close at or above CAD 0.40 ($0.30) per share on the Canadian Securities Exchange for ten consecutive trading days, the warrant expiry date shall accelerate to 90 days following notice of the acceleration event. The offering is expected to close in multiple tranches within 30 days, with the first closing occurring on or about July 14, 2023. The debentures, the warrants as well as the underlying shares, will be subject to a statutory hold period for a period of four months and one day from the closing date. The company may, at its option, increase the offering by an additional $1,000,000 for gross proceeds of up to $6,000,000.주주 수익률GRUS.FUS PharmaceuticalsUS 시장7D4.4%5.3%1.1%1Y3.6%44.3%28.7%전체 주주 수익률 보기수익률 대 산업: GRUS.F은 지난 1년 동안 44.3%의 수익을 기록한 US Pharmaceuticals 산업보다 저조한 성과를 냈습니다.수익률 대 시장: GRUS.F은 지난 1년 동안 28.7%를 기록한 US 시장보다 저조한 성과를 냈습니다.주가 변동성Is GRUS.F's price volatile compared to industry and market?GRUS.F volatilityGRUS.F Average Weekly Movement11.0%Pharmaceuticals Industry Average Movement9.9%Market Average Movement7.2%10% most volatile stocks in US Market16.4%10% least volatile stocks in US Market3.1%안정적인 주가: GRUS.F는 지난 3개월 동안 US 시장에 비해 주가 변동성이 크지 않았습니다.시간에 따른 변동성: GRUS.F의 주간 변동성(11%)은 지난 1년 동안 안정적이었습니다.회사 소개설립직원 수CEO웹사이트n/an/aJesse Stricklerwww.grownrogue.com크래프트 대마초 회사인 그로운 로그 인터내셔널은 프리미엄 꽃과 꽃에서 추출한 제품에 주력하고 있습니다. 이 회사는 인디카, 사티바, 잡종으로 분류되는 다양한 품종을 소비자를 위해 생산합니다. 이 회사는 약국을 통해 제품을 판매합니다.더 보기Grown Rogue International Inc. 기초 지표 요약Grown Rogue International의 순이익과 매출은 시가총액과 어떻게 비교됩니까?GRUS.F 기초 통계시가총액US$97.70m순이익 (TTM)-US$1.57m매출 (TTM)US$34.43m2.8x주가매출비율(P/S)-62.2x주가수익비율(P/E)GRUS.F는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표GRUS.F 손익계산서 (TTM)매출US$34.43m매출원가US$20.01m총이익US$14.42m기타 비용US$15.99m순이익-US$1.57m최근 보고된 실적Mar 31, 2026다음 실적 발표일해당 없음주당순이익(EPS)-0.0063총이익률41.88%순이익률-4.56%부채/자본 비율54.6%GRUS.F의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 13:08종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Grown Rogue International Inc.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Siddharth RajeevFundamental Research Corp.
공시 • May 14Grown Rogue International Inc. Revises Revenue Guidance for the Year 2026Grown Rogue International Inc. revised revenue guidance for the year 2026. For the year, the company expected revenue guidance to a range of $34 million to $37 million (up from $32 million to $35 million).
공시 • Apr 27Grown Rogue International Inc. to Report Q1, 2026 Results on May 12, 2026Grown Rogue International Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 12, 2026
공시 • Apr 09Grown Rogue International Inc. Provides Earnings Guidance for 2026 and 2027Grown Rogue International Inc. provided earnings guidance for 2026 and 2027. For 2026, the company expects revenue of $32- $35 million. For 2027, the company expects revenue of $50 - $58 million.
공시 • Apr 01Grown Rogue International Inc. to Report Fiscal Year 2025 Final Results on Apr 07, 2026Grown Rogue International Inc. announced that they will report fiscal year 2025 final results on Apr 07, 2026
공시 • Mar 31Grown Rogue International Inc. announced delayed annual 10-K filingOn 03/30/2026, Grown Rogue International Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Feb 18Grown Rogue International Inc. to Report Q4, 2025 Results on Mar 31, 2026Grown Rogue International Inc. announced that they will report Q4, 2025 results After-Market on Mar 31, 2026
공시 • May 14Grown Rogue International Inc. Revises Revenue Guidance for the Year 2026Grown Rogue International Inc. revised revenue guidance for the year 2026. For the year, the company expected revenue guidance to a range of $34 million to $37 million (up from $32 million to $35 million).
공시 • Apr 27Grown Rogue International Inc. to Report Q1, 2026 Results on May 12, 2026Grown Rogue International Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 12, 2026
공시 • Apr 09Grown Rogue International Inc. Provides Earnings Guidance for 2026 and 2027Grown Rogue International Inc. provided earnings guidance for 2026 and 2027. For 2026, the company expects revenue of $32- $35 million. For 2027, the company expects revenue of $50 - $58 million.
공시 • Apr 01Grown Rogue International Inc. to Report Fiscal Year 2025 Final Results on Apr 07, 2026Grown Rogue International Inc. announced that they will report fiscal year 2025 final results on Apr 07, 2026
공시 • Mar 31Grown Rogue International Inc. announced delayed annual 10-K filingOn 03/30/2026, Grown Rogue International Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Feb 18Grown Rogue International Inc. to Report Q4, 2025 Results on Mar 31, 2026Grown Rogue International Inc. announced that they will report Q4, 2025 results After-Market on Mar 31, 2026
공시 • Oct 21Grown Rogue International Inc. to Report Q3, 2025 Results on Nov 11, 2025Grown Rogue International Inc. announced that they will report Q3, 2025 results After-Market on Nov 11, 2025
공시 • Jul 21Grown Rogue International Inc. to Report Q2, 2025 Results on Aug 12, 2025Grown Rogue International Inc. announced that they will report Q2, 2025 results After-Market on Aug 12, 2025
공시 • May 02Grown Rogue International Inc., Annual General Meeting, Jul 03, 2025Grown Rogue International Inc., Annual General Meeting, Jul 03, 2025.
공시 • Apr 10Grown Rogue International Inc. to Report Q1, 2025 Results on May 13, 2025Grown Rogue International Inc. announced that they will report Q1, 2025 results on May 13, 2025
공시 • Feb 03Grown Rogue International Inc. Appoints Josh Rosen as Chief Strategy OfficerGrown Rogue International Inc. announced the hiring of Josh Rosen as the Company's new Chief Strategy Officer. As CSO, Josh will be responsible for leading Grown Rogue's capital allocation, business development and communication strategy, all in support of helping the Company execute on its vision to build a national craft cannabis brand. Prior to joining the Company, Josh has held numerous positions in the cannabis industry including Executive Chairman and CEO of 4Front Ventures and Chief Executive Officer of Vireo Growth Inc. Before joining 4Front in cannabis, Josh worked as a private equity portfolio manager, with the family office of John Sperling, who was a prominent drug reform philanthropist, and before that as an investment research analyst, primarily with Credit Suisse. Josh continues to serve as a Managing Partner of Bengal Capital, a cannabis investment and advisory firm.
공시 • Jan 02+ 1 more updateGrown Rogue International Inc. Appoints Andrew Marchington as Chief Financial OfficerGrown Rogue International Inc. appointed Andrew Marchington as the Company's new Chief Financial Officer and Corporate Secretary effective January 1, 2025. Ryan Kee will remain a member of the board of directors supporting the Company with his industry and financial reporting expertise. Andrew Marchington joined the Company as the Senior Vice President, Finance in June 2023. Prior to joining the Company, Andrew served as the Chief Financial Officer of Chalice Brands Ltd. and as Controller of C21 Investments Inc. Andrew is a licensed CPA in Oregon and has served a variety of finance and accounting roles both in and outside of the cannabis industry.
공시 • Jun 06Grown Rogue Receives Licensing Approval Approval with the New Jersey Cannabis Regulatory CommissionGrown Rogue International Inc. announced it has received licensing approval with the New Jersey Cannabis Regulatory Commission ("CRC") and closed its first option to acquire 44% of ABCO Garden State, LLC ("ABCO") on May 31, 2024. The transaction details are as follows: Grown Rogue has an option to acquire 70% of ABCO through two options; Option 1 was for 44% and Option 2 is for 26% ABCO has an annual cultivation license with the New Jersey Cannabis Regulatory Commission with local zoning and planning approvals and sufficient power supply Upon receiving licensing approval, the Company purchased Option 1 for USD 1,260,000, which has been paid in cash The Company anticipates exercising Option 2, pending regulatory approval, two years after operations commence. The purchase price for Option 2 is USD 720,000 Grown Rogue has the right to purchase the remaining equity of ABCO at fair market value.
공시 • Apr 26Grown Rogue International Inc., Annual General Meeting, Jun 24, 2024Grown Rogue International Inc., Annual General Meeting, Jun 24, 2024.
공시 • Mar 03Grown Rogue International Inc. announced delayed 20-F filingOn 03/01/2024, Grown Rogue International Inc. announced that they will be unable to file their next 20-F by the deadline required by the SEC.
공시 • Jul 14Grown Rogue International Inc. announced that it has received $5 million in funding from Mindset CapitalOn July 13, 2023, Grown Rogue International Inc. closed the transaction. The transaction was led by retuning investor, Mindset Capital. Additionally, on closing, the company issued to the subscribers under the offering an aggregate of 13,737,500 common share purchase warrants.
공시 • Jul 07Grown Rogue International Inc., Annual General Meeting, Oct 24, 2023Grown Rogue International Inc., Annual General Meeting, Oct 24, 2023.
공시 • Jul 06Grown Rogue International Inc. announced that it expects to receive $5 million in fundingGrown Rogue International Inc. announced a non-brokered private placement of unsecured convertible debentures with an aggregate principal amount of up to $5,000,000 on July 4, 2023. Each subscriber under the offering shall receive one-half of one common share purchase warrant for each CAD 0.24 ($0.18) of principal amount subscribed. The debentures will mature four years from the closing date, bear interest at a rate equal to 9% per annum, payable in united states currency on the last business day of the month following the end of each calendar quarter and are convertible as set forth below into common shares of the company. The debenture holders will be entitled, at their option, to convert, at any time on or prior to the maturity date, the outstanding Principal Amount and accrued interest into shares at a price per share equal to CAD 0.24 ($0.18). The company may elect to prepay the principal amount together with any interest thereon prior to the maturity date upon providing 30 days’ notice to the debenture holder. Each full Warrant will be exercisable into one share at an exercise price of CAD 0.28 ($0.21) for a period of three years from the closing date and are subject to an acceleration clause that in the event that the shares close at or above CAD 0.40 ($0.30) per share on the Canadian Securities Exchange for ten consecutive trading days, the warrant expiry date shall accelerate to 90 days following notice of the acceleration event. The offering is expected to close in multiple tranches within 30 days, with the first closing occurring on or about July 14, 2023. The debentures, the warrants as well as the underlying shares, will be subject to a statutory hold period for a period of four months and one day from the closing date. The company may, at its option, increase the offering by an additional $1,000,000 for gross proceeds of up to $6,000,000.
